Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Conserved Binding Sites01:49

Conserved Binding Sites

4.2K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.2K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Ligand Binding Sites02:40

Ligand Binding Sites

7.7K
7.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

De novo design of miniproteins targeting GPCRs.

Nature·2026
Same author

Machine Learning-Assisted Phase Diagram Determination in Aqueous Two-Phase Systems.

Langmuir : the ACS journal of surfaces and colloids·2026
Same author

AI-Enhanced Adaptive Virtual Screening Platform Enabling Exploration of 69 Billion Molecules Discovers Structurally Validated FSP1 Inhibitors.

bioRxiv : the preprint server for biology·2026
Same author

Scaling SMILES-based chemical language models for therapeutic peptide engineering.

bioRxiv : the preprint server for biology·2026
Same author

<i>Glp1r-Lepr</i> coexpressing neurons modulate the suppression of food intake and body weight by a GLP-1/leptin dual agonist.

Science translational medicine·2024
Same author

Nanobody repertoire generated against the spike protein of ancestral SARS-CoV-2 remains efficacious against the rapidly evolving virus.

eLife·2024

Related Experiment Video

Updated: Jun 14, 2025

A Fast and Quantitative Method for Post-translational Modification and Variant Enabled Mapping of Peptides to Genomes
09:10

A Fast and Quantitative Method for Post-translational Modification and Variant Enabled Mapping of Peptides to Genomes

Published on: May 22, 2018

9.2K

Structure-Based Computational Scanning of Chemical Modification Sites in Biologics.

Nidhin Thomas1, Tanmoy Sanyal1, Per Greisen1

  • 1Digital Science and Innovation, Novo Nordisk Research Center Seattle Inc., Seattle, Washington 98101, United States.

ACS Omega
|September 2, 2024
PubMed
Summary
This summary is machine-generated.

Chemically modifying peptide drugs with fatty acids improves their therapeutic properties. A new computational workflow combining RosettaMatch and molecular dynamics (MD) simulations speeds up the design of these modified biologics.

More Related Videos

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.0K
Author Spotlight: In Silico Creation and Impact of Carbonylated Amino Acids on Protein Structure and Function
05:57

Author Spotlight: In Silico Creation and Impact of Carbonylated Amino Acids on Protein Structure and Function

Published on: April 26, 2024

348

Related Experiment Videos

Last Updated: Jun 14, 2025

A Fast and Quantitative Method for Post-translational Modification and Variant Enabled Mapping of Peptides to Genomes
09:10

A Fast and Quantitative Method for Post-translational Modification and Variant Enabled Mapping of Peptides to Genomes

Published on: May 22, 2018

9.2K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.0K
Author Spotlight: In Silico Creation and Impact of Carbonylated Amino Acids on Protein Structure and Function
05:57

Author Spotlight: In Silico Creation and Impact of Carbonylated Amino Acids on Protein Structure and Function

Published on: April 26, 2024

348

Area of Science:

  • Biochemistry
  • Computational Biology
  • Drug Development

Background:

  • Peptide and protein drugs face challenges like short half-life and immunogenicity.
  • Chemical modification, particularly fatty acid derivatization, can enhance drug properties like half-life and biodistribution.
  • Current synthesis methods for modified biologics are inefficient, requiring extensive experimental testing and often yielding suboptimal products.

Purpose of the Study:

  • To develop an efficient computational workflow for designing chemically modified biologics.
  • To reduce the experimental burden in identifying optimal modification sites.
  • To accelerate the development of therapeutics with improved pharmacokinetic properties.

Main Methods:

  • Integration of RosettaMatch (from the Rosetta suite) with molecular dynamics (MD) simulations.
  • Development of a hybrid computational workflow for rational design of modified biologics.
  • Application of the workflow to fatty acid derivatization of peptide therapeutics, exemplified by GLP-1.

Main Results:

  • The computational workflow significantly reduces the number of amino acid positions requiring experimental validation.
  • The method expedites the design process for chemically modified biologics.
  • The approach facilitates the creation of modified biologics with desired pharmacokinetic enhancements.

Conclusions:

  • The hybrid computational workflow offers a rapid and cost-effective method for designing modified biologics.
  • This approach has broad potential for streamlining the development of various chemically modified therapeutics.
  • The strategy enables tailored improvements in the pharmacokinetic profiles of peptide and protein-based drugs.